Shares of Nemus Bioscience Inc (OTCMKTS:NMUS – Get Free Report) passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.80 and traded as low as $0.6833. Nemus Bioscience shares last traded at $0.70, with a volume of 194,116 shares changing hands.
Nemus Bioscience Stock Performance
The company has a market cap of $93.74 million, a price-to-earnings ratio of -7.78 and a beta of -0.04. The firm has a 50-day moving average of $0.80.
Nemus Bioscience Company Profile
Nemus Bioscience, Inc is an early‐stage biopharmaceutical company developing proprietary prodrug cannabinoid therapeutics for ophthalmic, dermatological and metabolic diseases. The company leverages synthetic derivatives of naturally occurring cannabinoids, designed to improve bioavailability, tissue targeting and therapeutic efficacy. Nemus operates under an OTCMKTS listing and is headquartered in Houston, Texas.
The company’s pipeline includes multiple preclinical candidates, with lead programs focusing on ophthalmic and dermatological indications.
See Also
- Five stocks we like better than Nemus Bioscience
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for Nemus Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nemus Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
